Cardinal Health (CAH) Tops Q3 EPS by 7c, Miss on Revenue; Reaffirms FY EPS Guidance at Bottom of Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cardinal Health (CAH) PT Raised to $78 at Evercore ISI
May 1, 2017 11:05 AM EDTEvercore ISI bumped its price target on Cardinal Health (NYSE: CAH) modestly to $78.00 (from $77.50) while maintaining a Outperform rating following Q1 results.
Analyst Ross Muken said while the company didn't have any new surprises, they view Pharma momentum as slightly above... More
Tigress Financial Partners Starts Cardinal Health (CAH) at Neutral
April 30, 2017 2:30 PM EDTTigress Financial Partners initiates coverage on Cardinal Health (NYSE: CAH) with a Neutral rating.
Analyst Ivan Feinseth says the company has "extremely low" Economic Operating Cash Flow and Economic Profit margin while acknowledging the company's strong revenue growth. He sees low margins... More
